advertisement

WGC-2027

Martínez-de-la-Casa JM 20

Showing records 1 to 20 | Display all abstracts from Martínez-de-la-Casa JM

118259 Preserflo TM MicroShunt implantation combined with Ologen TM in primary and secondary glaucoma patients in a clinical setting
Rojo-Arnao M
Indian Journal of Ophthalmology 2024; 72: 417-426
117994 XEN-45 in the management of early glaucoma surgery: A national Delphi consensus study
Larrosa JM
Archivos de la Sociedad Espanola de Oftalmologia 2024; 99: 98-108
116865 Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma
Martínez-de-la-Casa JM
Scientific reports 2024; 14: 4561
118259 Preserflo TM MicroShunt implantation combined with Ologen TM in primary and secondary glaucoma patients in a clinical setting
Martínez-de-la-Casa JM
Indian Journal of Ophthalmology 2024; 72: 417-426
116865 Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma
Marcos-Parra MT
Scientific reports 2024; 14: 4561
117994 XEN-45 in the management of early glaucoma surgery: A national Delphi consensus study
Martínez-de-la-Casa JM; Giménez Gómez R
Archivos de la Sociedad Espanola de Oftalmologia 2024; 99: 98-108
116865 Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma
Millá-Griñó E
Scientific reports 2024; 14: 4561
118259 Preserflo TM MicroShunt implantation combined with Ologen TM in primary and secondary glaucoma patients in a clinical setting
Albis-Donado O
Indian Journal of Ophthalmology 2024; 72: 417-426
117994 XEN-45 in the management of early glaucoma surgery: A national Delphi consensus study
Goñi FJ
Archivos de la Sociedad Espanola de Oftalmologia 2024; 99: 98-108
116865 Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma
Laborda T
Scientific reports 2024; 14: 4561
118259 Preserflo TM MicroShunt implantation combined with Ologen TM in primary and secondary glaucoma patients in a clinical setting
Yañez-Castro G
Indian Journal of Ophthalmology 2024; 72: 417-426
117994 XEN-45 in the management of early glaucoma surgery: A national Delphi consensus study
Millá E
Archivos de la Sociedad Espanola de Oftalmologia 2024; 99: 98-108
116865 Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma
Giménez-Gómez R
Scientific reports 2024; 14: 4561
118259 Preserflo TM MicroShunt implantation combined with Ologen TM in primary and secondary glaucoma patients in a clinical setting
Maroto-Cejudo R; Téllez J
Indian Journal of Ophthalmology 2024; 72: 417-426
116865 Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma
Larrosa JM
Scientific reports 2024; 14: 4561
117994 XEN-45 in the management of early glaucoma surgery: A national Delphi consensus study
Pazos M; Perucho Martínez S
Archivos de la Sociedad Espanola de Oftalmologia 2024; 99: 98-108
116865 Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma
Urcola A
Scientific reports 2024; 14: 4561
118259 Preserflo TM MicroShunt implantation combined with Ologen TM in primary and secondary glaucoma patients in a clinical setting
Menoyo-Calatayud R
Indian Journal of Ophthalmology 2024; 72: 417-426
117994 XEN-45 in the management of early glaucoma surgery: A national Delphi consensus study
Urcola Carrera JA
Archivos de la Sociedad Espanola de Oftalmologia 2024; 99: 98-108
116865 Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma
Teus MÁ; Perucho-Martínez S
Scientific reports 2024; 14: 4561

Issue 24-4

Change Issue


advertisement

WGA Rescources